semaglutide + tirzepatide Maintenance therapy on or What Is the Difference Between

Understanding proper storage, recognizing signs of degradation, and distinguishing medication potency from natural metabolic adaptation are essential for optimal treatment outcomes

Semaglutide (as Wegovy) and tirzepatide (as Zepbound) are the two main GLP-1 and dual-receptor options FDA-approved for weight management

See What Is GLP-1

Therefore, postmarketing surveillance and real-world evidence play a crucial role in continuously monitoring the safety and effectiveness of medications once they are in widespread use [Reference Zhou, Peng, Lin, Jiang, Peng and Gu29Reference Fan, Hu, Yang and Zhao31]

After the initial check-in, follow-up appointments are typically scheduled at each dose escalation and then monthly once you reach your maintenance dose